Jasper Therapeutics is Drug Discovery in United States that focus on hematopoietic transplantation business. Founded in 2018. They cover business area such as developer, novel therapeutic, safe and curative hematopoietic transplantation, hematopoietic stem cell transplant, indication, hematologic cancer, orphan immunological condition, non-malignant hematologic condition, autoimmune disease, medical practitioner, transplant graft.
2018
( 6 years old in 2024 )
Hematopoietic Transplantation
-
2200 Bridge Parkway
Suite 102
Redwood City, CA 94065
United States
Private
developernovel therapeuticsafe and curative hematopoietic transplantationhematopoietic stem cell transplantindicationhematologic cancerorphan immunological conditionnon-malignant hematologic conditionautoimmune diseasemedical practitionertransplant graft
* We use standard office opening hours in near Jasper Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Jasper Therapeutics is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Jasper Therapeutics business is focusing on Hematopoietic Transplantation.
Jasper Therapeutics headquarter office and corporate office address is located in 2200 Bridge Parkway Suite 102 Redwood City, CA 94065 United States.
Jasper Therapeutics was founded in United States.
In 2024, Jasper Therapeutics is currently focus on hematopoietic transplantation sector.
Above is snippet of Google Trends for "hematopoietic transplantation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Jasper Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
